- Home
- LSTA vs SCNX Comparison
LSTA vs SCNX Comparison
Compare LSTA & SCNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSTA
- SCNX
- Stock Information
- Founded
- LSTA 1980
- SCNX 2010
- Country
- LSTA United States
- SCNX United States
- Employees
- LSTA N/A
- SCNX N/A
- Industry
- LSTA Misc Health and Biotechnology Services
- SCNX Other Pharmaceuticals
- Sector
- LSTA Health Care
- SCNX Health Care
- Exchange
- LSTA Nasdaq
- SCNX Nasdaq
- Market Cap
- LSTA 20.0M
- SCNX 33.6M
- IPO Year
- LSTA N/A
- SCNX 2020
- Fundamental
- Price
- LSTA $2.21
- SCNX $1.19
- Analyst Decision
- LSTA Strong Buy
- SCNX
- Analyst Count
- LSTA 1
- SCNX 0
- Target Price
- LSTA $15.00
- SCNX N/A
- AVG Volume (30 Days)
- LSTA 17.1K
- SCNX 2.6M
- Earning Date
- LSTA 02-27-2025
- SCNX 03-18-2025
- Dividend Yield
- LSTA N/A
- SCNX N/A
- EPS Growth
- LSTA N/A
- SCNX N/A
- EPS
- LSTA N/A
- SCNX 3.55
- Revenue
- LSTA $1,000,000.00
- SCNX N/A
- Revenue This Year
- LSTA N/A
- SCNX $1,085.75
- Revenue Next Year
- LSTA N/A
- SCNX N/A
- P/E Ratio
- LSTA N/A
- SCNX $0.53
- Revenue Growth
- LSTA N/A
- SCNX 166.67
- 52 Week Low
- LSTA $2.05
- SCNX $1.13
- 52 Week High
- LSTA $4.20
- SCNX $33.28
- Technical
- Relative Strength Index (RSI)
- LSTA 38.28
- SCNX N/A
- Support Level
- LSTA $2.05
- SCNX N/A
- Resistance Level
- LSTA $2.46
- SCNX N/A
- Average True Range (ATR)
- LSTA 0.20
- SCNX 0.00
- MACD
- LSTA 0.01
- SCNX 0.00
- Stochastic Oscillator
- LSTA 32.81
- SCNX 0.00
About LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Its product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively.
About SCNX Scienture Holdings Inc. Common Stock
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs and optimize the prescription journey and patient engagement in the U.S.